Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 6—June 2007
Letter

Multidrug-Resistant Acinetobacter baumannii

Vladimir Krcmery*Comments to Author  and Erich Kalavsky†
Author affiliations: *St Elizabeth School of Health and Social Sciences, Bratislava, Slovakia; †Trnava University, Trnava, Slovakia

Main Article

Table

Risk factors and outcome for 27 neutropenic cancer patients with bacteremia due to multidrug-resistant (MDR) or drug-susceptible Acinetobacter baumannii infection

Characteristic All patients, no. (%)
(N = 27) Patients with drug-susceptible A. baumannii, no. (%)*
(n = 12, 44%) Patients with MDR
A. baumannii, no. (%)*
(n = 15, 56%)
Risk for bacteremia
Central venous catheter 19 (70.4) 9 (75.0) 10 (66.7)
Acute leukemia 11 (40.7) 6 (50.0) 5 (33.3)
Previous prophylaxis with quinolones 14 (51.9) 8 (66.7) 6 (40.0)
Previous therapeutic treatment with cephalosporins 15 (55.6) 8 (66.7) 7 (46.7)
Previous therapeutic treatment with carbapenems 8 (29.6) 4 (33.3) 4 (26.7)
Outcome
Septic shock 4 (14.8) 2 (16.7) 2 (13.3)
Death 2 (7.4) 1 (8.3) 1 (6.7)

*Insignificant difference between patients with drug-susceptible infection and those with MDR infection (p<0.05 by univariate analysis).

Main Article

Page created: July 05, 2010
Page updated: July 05, 2010
Page reviewed: July 05, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external